BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 9481611)

  • 1. Cardiovascular T-type calcium channels: physiological and pharmacological significance.
    Triggle DJ
    J Hypertens Suppl; 1997 Dec; 15(5):S9-15. PubMed ID: 9481611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
    Aczél S; Kurka B; Hering S
    Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells.
    Nilius B; Prenen J; Kamouchi M; Viana F; Voets T; Droogmans G
    Br J Pharmacol; 1997 Jun; 121(3):547-55. PubMed ID: 9179399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue.
    Brixius K; Mohr V; Müller-Ehmsen J; Hoischen S; Münch G; Schwinger RH
    Br J Pharmacol; 1998 Sep; 125(1):41-8. PubMed ID: 9776342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart.
    Emanuel K; Mackiewicz U; Pytkowski B; Lewartowski B
    J Physiol Pharmacol; 1998 Dec; 49(4):577-90. PubMed ID: 10069698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
    Sarsero D; Fujiwara T; Molenaar P; Angus JA
    Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.
    Mehrke G; Zong XG; Flockerzi V; Hofmann F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1483-8. PubMed ID: 7996461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The physiological and pharmacological significance of cardiovascular T-type, voltage-gated calcium channels.
    Triggle DJ
    Am J Hypertens; 1998 Apr; 11(4 Pt 3):80S-87S. PubMed ID: 9607371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of the T-type Ca2+ current of mouse spermatogenic cells.
    Arnoult C; Villaz M; Florman HM
    Mol Pharmacol; 1998 Jun; 53(6):1104-11. PubMed ID: 9614215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mibefradil, a pharmacologically distinct calcium antagonist.
    Ernst ME; Kelly MW
    Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells.
    Rossier MF; Ertel EA; Vallotton MB; Capponi AM
    J Pharmacol Exp Ther; 1998 Dec; 287(3):824-31. PubMed ID: 9864260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term hemodynamic effects of mibefradil in dogs with chronic heart failure: comparison with diltiazem.
    Shimoyama H; Sabbah HN; Tanimura M; Borzak S; Goldstein S
    J Pharmacol Exp Ther; 1998 May; 285(2):746-52. PubMed ID: 9580622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel diversity in the cardiovascular system.
    Katz AM
    J Am Coll Cardiol; 1996 Aug; 28(2):522-9. PubMed ID: 8800134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967).
    Avdonin PV; Buhler FR; Tkachuk VA
    Membr Cell Biol; 2000; 13(5):645-55. PubMed ID: 10987388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
    Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
    Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+ flux through voltage-gated channels with flow cessation in pulmonary microvascular endothelial cells.
    Wei Z; Manevich Y; Al-Mehdi AB; Chatterjee S; Fisher AB
    Microcirculation; 2004 Sep; 11(6):517-26. PubMed ID: 15371132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones.
    Viana F; Van den Bosch L; Missiaen L; Vandenberghe W; Droogmans G; Nilius B; Robberecht W
    Cell Calcium; 1997 Oct; 22(4):299-311. PubMed ID: 9481480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.